Twice daily administration of intravenous deoxyribonuclease I (ivDNase I) in 2 models of anti-MPO GN reduced glomerular deposition of ecDNA, histological injury, leukocyte infiltration, and NETosis. Here, MPO is linked to ganglioneuroma.